Evolent Health [EVH] vs Teladoc Health [TDOC] Detailed Stock Comparison

Evolent Health Inc.

NYSE
Loading...

Teladoc Health Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Evolent Health Inc. wins in 8 metrics, Teladoc Health Inc. wins in 9 metrics, with 1 ties. Teladoc Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Evolent Health Inc. Teladoc Health Inc. Better
P/E Ratio (TTM) -0.58 N/A N/A
Price-to-Book Ratio 0.85 0.74 Teladoc Health Inc.
Debt-to-Equity Ratio 238.37 75.06 Teladoc Health Inc.
PEG Ratio 0.00 -6.16 Tie
EV/EBITDA 13.48 38.86 Evolent Health Inc.
Profit Margin (TTM) -28.49% -7.92% Teladoc Health Inc.
Operating Margin (TTM) -2.06% -4.20% Evolent Health Inc.
Return on Equity -66.54% -13.93% Teladoc Health Inc.
Return on Assets (TTM) -0.13% -3.20% Evolent Health Inc.
Free Cash Flow (TTM) $4.76M $137.33M Teladoc Health Inc.
1-Year Return -41.96% 7.00% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 0.19 0.41 Evolent Health Inc.
Enterprise Value $1.19B $1.28B Teladoc Health Inc.
EV/Revenue Ratio 0.63 0.51 Teladoc Health Inc.
Gross Profit Margin (TTM) 20.75% 69.32% Teladoc Health Inc.
Revenue per Share (TTM) $16 $14 Evolent Health Inc.
Earnings per Share (Diluted) $-5.07 $-34.20 Evolent Health Inc.
Beta (Stock Volatility) 0.37 2.08 Evolent Health Inc.
Short % of Float 14.47% 16.55% Evolent Health Inc.

Evolent Health Inc. vs Teladoc Health Inc. Stock Performance Analysis

Loading Price Chart...

EVH
TDOC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Evolent Health Inc.-2.08%0.86%18.69%55.63%14.08%20.82%
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Evolent Health Inc.-41.96%-83.22%-75.66%-70.50%-74.55%-74.55%
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%

Performance & Financial Health Analysis: Evolent Health Inc. vs Teladoc Health Inc.

MetricEVHTDOC
Market Information
Market Cap i$329.33M$1.04B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,779,2874,716,750
90 Day Avg. Volume i2,982,7064,439,277
Last Close$4.70$7.46
52 Week Range$2.10 - $12.06$4.40 - $9.77
% from 52W High-61.04%-23.64%
All-Time High$39.78 (Sep 12, 2022)$308.00 (Feb 15, 2021)
% from All-Time High-88.19%-97.58%
Growth Metrics
Quarterly Revenue Growth-0.28%0.00%
Quarterly Earnings GrowthN/A0.00%
Financial Health
Profit Margin (TTM) i-0.28%-0.08%
Operating Margin (TTM) i-0.02%-0.04%
Return on Equity (TTM) i-0.67%-0.14%
Debt to Equity (MRQ) i238.3775.06
Cash & Liquidity
Book Value per Share (MRQ)$3.72$7.77
Cash per Share (MRQ)$1.36$4.38
Operating Cash Flow (TTM) i$38.84M$294.36M
Levered Free Cash Flow (TTM) i$98.41M$226.14M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Evolent Health Inc. vs Teladoc Health Inc.

MetricEVH (Apr 24, 2026)TDOC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-0.58N/A
Forward P/E i7.13-6.16
PEG Ratio i0.00-6.16
Price to Sales (TTM) i0.190.41
Price to Book (MRQ) i0.850.74
Market Capitalization
Market Capitalization i$329.33M$1.04B
Enterprise Value i$1.19B$1.28B
Enterprise Value Metrics
Enterprise to Revenue i0.630.51
Enterprise to EBITDA i13.4838.86
Risk & Other Metrics
Beta i0.372.08
Book Value per Share (MRQ) i$3.72$7.77

Financial Statements Comparison: Evolent Health Inc. vs Teladoc Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVH (2025)TDOC (2025)
Revenue/Sales i1.88B2.53B
Cost of Goods Sold i1.48B771.59M
COGS % of Revenue i78.7%30.5%
Gross Profit i399.88M1.76B
Gross Margin i21.3%69.5%
Research & Development iN/A277.92M
Operating Income (EBIT) i-19.83M-163.40M
Operating Margin i-1.1%-6.5%
EBITDA i85.02M260.18M
EBITDA Margin i4.5%10.3%
Pre-Tax Income i-534.64M-235.53M
Pre-Tax Income % of Revenue i-28.5%-9.3%
Income Tax i-126,000-35.21M
Income Tax % of Revenue i0.0%-1.4%
Net Income (Profit) i-534.51M-200.32M
Profit Margin i-28.5%-7.9%

Balance Sheet & Liquidity Metrics

MetricEVH (2025)TDOC (2025)
Cash & Equivalents i151.86M781.08M
Total Current Assets i506.37M1.12B
Total Current Assets % of Revenue i27.0%44.2%
Total Current Liabilities i385.26M404.74M
Total Current Liabilities % of Revenue i20.5%16.0%
Long-Term Debt i974.36M1.03B
Long-Term Debt % of Revenue i51.9%40.7%
Total Shareholders Equity i415.19M1.39B
Retained Earnings i-1.32B-16.43B
Retained Earnings % of Revenue i-70.1%-649.4%
Property, Plant & Equipment i4.37M42.03M

Cash Flow Statement Comparison

MetricEVH (2025)TDOC (2025)
Operating Cash Flow i-425.17M225.59M
Operating Cash Flow % of Revenue i-22.7%8.9%
Capital Expenditures iN/AN/A
Free Cash Flow i4.76M137.33M
FCF Margin i0.3%5.4%
Debt Repayment i-342.98M-550.63M
Common Stock Repurchase i-40.00MN/A

Short Interest & Institutional Ownership Analysis

MetricEVHTDOC
Shares Short i15.95M29.71M
Short Ratio i5.146.89
Short % of Float i14.47%16.55%
Shares Outstanding i111.63M178.32M
Float Shares i92.79M176.23M
% Held by Insiders i1.62%0.65%
% Held by Institutions i110.52%75.86%
% Held by Public i-12.14%23.49%

Dividend Analysis & Yield Comparison: Evolent Health Inc. vs Teladoc Health Inc.

MetricEVHTDOC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A